Migraine medications

16,884views

Migraine medications

BMB2

BMB2

Seizures: Pathology review
Seizures: Clinical
Febrile seizure
Seizures and epilepsy
Early infantile epileptic encephalopathy (NORD)
Nonbenzodiazepine anticonvulsants
Migraine medications
Migraine
Neuron action potential
Resting membrane potential
Concussion and traumatic brain injury
Sleep
Sleep disorders: Clinical
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Essential tremor
Malingering, factitious disorders and somatoform disorders: Pathology review
Somatic symptom disorders: Clinical
Somatic symptom disorder
Dissociative disorders
Dissociative disorders: Clinical
Amnesia, dissociative disorders and delirium: Pathology review
Narcolepsy (NORD)
Psychomotor stimulants
Trigeminal neuralgia
Muscle weakness: Clinical
Myalgias and myositis: Pathology review
Fibromyalgia
Diabetic nephropathy
Tricyclic antidepressants
Atypical antidepressants
Medications for neurodegenerative diseases
Toxidromes: Clinical
Body focused repetitive disorders
Headaches: Clinical
Demyelinating disorders: Pathology review
Serotonin and norepinephrine reuptake inhibitors
Erb-Duchenne palsy
Klumpke paralysis
Lead poisoning
Hemolytic-uremic syndrome
Vitamin B12 deficiency
Monoclonal gammopathy of undetermined significance
Charcot-Marie-Tooth disease
Inflammatory myopathies: Clinical
Guillain-Barre syndrome
Amyotrophic lateral sclerosis
Spinal muscular atrophy
Muscular dystrophy
Spinal cord reflexes
Myotonic dystrophy
Memory palaces
Herpes simplex virus
Neuromuscular junction and motor unit
Slow twitch and fast twitch muscle fibers
Muscle contraction
Development of the muscular system
Development of the axial skeleton
Patellar tendon rupture
Achilles tendon rupture
Lower back pain: Clinical
Carpal tunnel syndrome
Radial head subluxation (Nursemaid elbow)
Bell palsy
Headaches: Pathology review
Cluster headache
Tension headache
Epidural hematoma
Traumatic brain injury: Clinical
Intracerebral hemorrhage
Subarachnoid hemorrhage
Subdural hematoma
Traumatic brain injury: Pathology review
Idiopathic intracranial hypertension
Vasculitis
Vasculitis: Clinical
Dementia with Lewy bodies
Spinocerebellar ataxia (NORD)
Amyloidosis
Vascular dementia
Dementia and delirium: Clinical
Frontotemporal dementia
Dementia: Pathology review
Hypokinetic movement disorders: Clinical
Alzheimer disease
Movement disorders: Pathology review
Delirium
Parkinson disease
Hyperkinetic movement disorders: Clinical
Back pain: Pathology review
Stroke: Clinical
Compartment syndrome
Macrocytic anemia: Pathology review
Hypokalemia: Clinical
Hyperkalemia: Clinical
Hypothesis testing: One-tailed and two-tailed tests
Paired t-test
One-way ANOVA
Two-way ANOVA
Type I and type II errors
Two-sample t-test
Correlation
Repeated measures ANOVA
Meningitis, encephalitis and brain abscesses: Clinical
Neonatal meningitis
Central nervous system infections: Pathology review
Neisseria meningitidis
Streptococcus pneumoniae
Listeria monocytogenes
Brain abscess
Clostridium tetani (Tetanus)
Clostridium botulinum (Botulism)
Encephalitis
Eastern and Western equine encephalitis virus
West Nile virus
Zika virus
Rabies virus
Poliovirus
JC virus (Progressive multifocal leukoencephalopathy)
Knowledge Shot: What is acute flaccid myelitis, the polio-like paralyzing disease
Meningitis
Cryptococcus neoformans
Aspergillus fumigatus
Candida
Mucormycosis
Coccidioidomycosis and paracoccidioidomycosis
Blastomycosis
Histoplasmosis
Chi-squared test
Naegleria fowleri (Primary amebic meningoencephalitis)
Angiostrongylus (Eosinophilic meningitis)
Varicella zoster virus
Mycobacterium tuberculosis (Tuberculosis)
Normal pressure hydrocephalus
Prions (Spongiform encephalopathy)
Measles virus
Central nervous system infections: Pathology review
Meningitis, encephalitis and brain abscesses: Clinical
Adult brain tumors
Pediatric brain tumors: Pathology review
Adult brain tumors: Pathology review
Pediatric brain tumors
Brain tumors: Clinical
Multiple sclerosis
Tourette syndrome
Ataxia-telangiectasia
Huntington disease
Opsoclonus myoclonus syndrome (NORD)
Primary ciliary dyskinesia
Brain herniation
Spinal disc herniation
Multiple myeloma

Transcript

Watch video only

Migraine medications include a wide variety of drugs used to treat a specific type of headache called migraine.

Migraines are the second most common primary headache.

They’re often preceded by symptoms like irritability, depression, and fatigue that can begin hours to days before the headache itself. Sometimes there can be an aura where people experience strange smells, lights, visual disturbances, or even hallucinations before the onset of the migraine.

The migraine itself usually feels like a pounding or pulsating, typically localized to one side of the head and can last from hours to days.

As if this was not bad enough, these headaches tend to come with nausea and vomiting, irritability, and pain or discomfort with lights, sounds, and smells called photophobia, phonophobia, and osmophobia, respectively.

During childhood, individuals can have nausea and vomiting without the headaches; and that’s called an abdominal migraine.

After a migraine is over, it can leave people feeling sore at the location of the pain and generally fatigued.

To remember the main features of migraines, you can use the mnemonic POUND, where P stands for pulsatile headache, O stands for one-day duration, U stands for unilateral, N for nausea, and D for disabling.

Although the underlying mechanism causing migraines isn’t well understood, there are some clues.

Concentrations of the neurotransmitter, serotonin, increase during the aura, triggering vasoconstriction, and then decrease to lower-than-normal levels during the migraine attack, triggering vasodilation. This change in the blood vessel size may be a trigger for pain receptors, causing the headache.

The initial vasoconstriction may also trigger cortical spreading depression, which is a phenomenon when the brain becomes hypersensitive to certain stimuli like lights, sounds, and smells.

Migraines are often associated with specific triggers like the smell of cigarette smoke, foods like chocolate or cheese, and drinking wine.

Even sleeping too much or too little can sometimes trigger a migraine.

There are two treatment approaches for migraine: acute treatment to help manage the pain; and preventive treatment to keep headaches from happening in the first place, in individuals that have severe, debilitating headaches.

The acute treatment includes common analgesic drugs, triptans, and ergot alkaloids.

For people with mild or moderate symptoms, initial treatment may involve only analgesics, such as NSAIDs or the opioid agonist butorphanol.

Acutely, pain medications work best if they’re used at the first sign of an attack, during the early symptoms, and aura.

If the pain is very severe, triptans or ergotamine, which are serotonin agonists, can be useful because they mimic serotonin to cause vasoconstriction.

So, triptans should be prescribed when people with mild symptoms don’t respond to analgesics, or when symptoms are moderate to severe.

The common suffix for these medications is -triptan, like sumatriptan, zolmitriptan, naratriptan, or rizatriptan.

All of them can be given by mouth, but this may be impractical for people who have nausea or vomiting during the attack. For these situations, subcutaneous injections or a nasal spray of sumatriptan are available.

Triptans are agonists at 5-HT1B and 5HT1D serotonin receptors, therefore preventing vasoactive peptide release, reducing trigeminal nerve activation, and causing vasoconstriction.

Side effects are generally mild, and include mild pain or burning sensations at the site of injection, paresthesia, fatigue, or dizziness, when given per orally.

In addition, not only do they cause vasoconstriction on the blood vessels in the brain, but also in other blood vessels, which can raise blood pressure.

Also, as it causes coronary vasospasm, it can bring about a type of chest pain called angina. Although it’s an uncommon side effect, that’s why triptans are contraindicated in people with hypertension, coronary artery disease, prinzmetal angina, and peripheral vascular disease.

It can also rarely cause myocardial ischemia or infarction, and arrhythmias as well.

Now, when used together with other serotonin receptor agonists, triptans can induce a serotonin syndrome, that comprises of cognitive symptoms, like headache, hallucinations, or coma; somatic symptoms, like tremors or hyperreflexia; and autonomic symptoms like tachycardia, nausea, diarrhoea, shivering, and sweating. So, people who have recently been given ergot alkaloids or other serotonin agonists mustn’t use triptans, at least for 24 hours.

Okay so, sometimes, NSAIDs or triptans aren’t effective to relieve the symptoms. So we can move on to the ergot alkaloids, or simply ‘ergots’, which include ergotamine and dihydroergotamine.

Ergotamine can be administered in sublingual tablets, and dihydroergotamine can be injected or used as a nasal spray.

Ergots are also agonist at 5-HT serotonin receptors. However, they're not specific for 5-HT1 receptors, and that means they have more side effects than triptans.

For example, when they stimulate 5HT3 receptors in the vomiting center of the brain, they can trigger nausea or vomiting.

Also, just like triptans, ergot alkaloids causes vasoconstriction and are contraindicated in people with coronary artery disease or hypertension.

In a similar aspect, as ergot stimulate contraction of the smooth muscle in the wall of blood vessels, they also stimulate contraction of the uterine smooth muscle, an oxytocic effect that can lead to premature labor in pregnant women, causing fetal distress and miscarriage. So, they’re contraindicated during pregnancy.

Ergot alkaloids are widely metabolized in the liver, that’s why they’re contraindicated in patients with liver impairment.

Sources

  1. "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
  2. "Rang and Dale's Pharmacology" Elsevier (2019)
  3. "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)
  4. "Treatment of acute migraine headache" Am Fam Physician (2011)
  5. "Migraine Headache Prophylaxis" Am Fam Physician (2019)
  6. "Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date" Clin Pharmacol Drug Dev (2017)
  7. "Triptans and ergot alkaloids in the acute treatment of migraine: similarities and differences" Expert Review of Neurotherapeutics (2013)
  8. "The pathophysiology of migraine: implications for clinical management" Lancet Neurol (2018)